← Leaderboards
David N. Newbold
Orbis Biosciences, Inc.
$173,793
Attributed
$695,173
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $349.5K · FY2010–11$500K$375K$250K$125K$0
'10
'11
Funding mix
By agency
NIH$695,173 · 1
By mechanism
R43$695,173 · 1
Top collaborators
- Cory Berkland2 shared
- Ronald Arthur Beyerinck2 shared
- Maria Flynn2 shared
Most similar at Orbis Biosciences, Inc.
Same institution · by research overlap
- Nathan H Dormer$4,888,977
- Maria Flynn$258,353
- Milind Singh$210,328
- Ronald Arthur Beyerinck$173,793
- David Dumbauld$125,769
Others in their field
Top investigators on “Antibiotics”
- Laurence H Baker · University Of Michigan At Ann Arbor$52,071,546
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Taha E Taha · Johns Hopkins University$37,363,329
- Urs Ochsner · Crestone, Inc.$36,950,837
- Deborah T Hung · Massachusetts General Hospital$36,871,538
- Ryan Cirz · Revagenix, Inc.$35,410,554
Research focus
AntibioticsBaseBedsBeveragesBiologicalBiological AvailabilityBusinessesCharacteristicsChildhoodControlled ReleaseCostDesignDoseDrug ControlsDrug Delivery SystemsDrug DevelopmentDrug IndustryEffectivenessEncapsulatedEquipmentFailure (Biologic Function)FiltrationFlexibilityFunding